Augmented epithelial endothelin-1 expression in refractory asthma.

Area of Science:

• Pulmonary Medicine
• Respiratory Research
• Molecular Biology

Background:

• Severe steroid-refractory asthma is associated with airway remodeling.
• Steroid therapy may be less effective in limiting remodeling factors in these patients.

Purpose of the Study:

• To compare transcript levels of remodeling factors in the bronchial epithelium of healthy individuals and asthmatic patients (steroid-sensitive vs. steroid-refractory).
• To correlate these transcript levels with airway remodeling indicators.

Main Methods:

• Real-time quantitative PCR was used to measure 14 transcripts in laser-capture microdissected bronchial epithelium.
• Groups included healthy volunteers, mild steroid-untreated asthma, steroid-sensitive asthma, and steroid-refractory asthma.
• Histology and endothelin-1 (EDN1) immunolocalization were performed on frozen specimens.

Main Results:

• Patients with steroid-refractory asthma showed significantly higher levels of EDN1 transcripts and protein compared to steroid-sensitive asthmatics.
• Increased EDN1 levels correlated negatively with FEV1 (lung function) and positively with airway smooth muscle area.
• A 4.1-fold increase in EDN1 transcripts and significant protein increase were observed in refractory asthma.

Conclusions:

• Elevated endothelin-1 (EDN1) synthesis in bronchial epithelium is a characteristic of severe refractory asthma.
• EDN1 levels correlate with airway remodeling and airflow obstruction in asthmatic patients.
• Targeting EDN1 presents a potential novel therapeutic strategy for severe steroid-refractory asthma.